Liver Diseases  >>  VRDN-001  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
VRDN-001 / Viridian Therap
NCT00791544: Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma

Terminated
1/2
13
Europe
AVE1642, sorafenib, Nevaxar, erlotinib, Tarceva
Sanofi
Liver Carcinoma
11/09
11/09

Download Options